Study #2023-0134
A phase 1, open-label, sequential cross-over, bioavailability/bioequivalence study to compare the pharmacokinetics of oral Cladribine with the reference listed drug, intravenous Cladribine
MD Anderson Study Status
Not Accepting
Treatment Agent
Cladribine
Description
To compare an investigational oral form of the drug cladribine to the FDA approved form of the drug when it is given by vein (IV).
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Leukemia, Myelodysplastic Syndromes, Acute Myeloid Leukemia
Study phase:
Phase I
Physician name:
Farhad Ravandi-Kashani
Department:
Leukemia
For general questions about clinical trials:
1-844-794-1615
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.